View Older Stories View More Recent Stories

Apr 1, 2025 07:05AM Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
Mar 31, 2025 04:01PM Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Mar 24, 2025 07:05AM Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call 
Feb 25, 2025 07:05AM Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences
Dec 11, 2024 07:05AM Celcuity (CELC) Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy
Dec 11, 2024 07:05AM Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
Nov 14, 2024 04:01PM Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update
Nov 12, 2024 07:05AM Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences
Nov 7, 2024 07:05AM Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call
Aug 14, 2024 04:01PM Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update
Aug 7, 2024 07:05AM Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call
Jun 3, 2024 04:01PM Celcuity To Participate in Jefferies Global Healthcare Conference
May 30, 2024 07:05AM Celcuity (CELC) Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
May 30, 2024 07:00AM Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
May 15, 2024 04:01PM Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
May 8, 2024 07:05AM Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
Apr 4, 2024 07:05AM Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
Mar 27, 2024 04:01PM Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Mar 20, 2024 07:05AM Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
Mar 6, 2024 07:05AM Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
Feb 28, 2024 07:05AM Celcuity to Participate in Cowen’s 44th Annual Health Care Conference
Feb 22, 2024 04:05PM Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
Feb 20, 2024 07:05AM Celcuity (CELC) Appoints Eldon Mayer as Chief Commercial Officer
Feb 20, 2024 07:05AM Celcuity Appoints Eldon Mayer as Chief Commercial Officer
Dec 6, 2023 08:30AM Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
Dec 1, 2023 11:02AM Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
Nov 22, 2023 08:05AM Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
Nov 13, 2023 07:05AM Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
Nov 6, 2023 07:30AM Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call
Nov 1, 2023 07:05AM Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences
Sep 7, 2023 04:05PM Celcuity to Host Virtual Science Day for Investors
Aug 22, 2023 04:05PM Celcuity (CELC) Enters a Clinical Trial Collaboration and Supply Agreement with Bayer to Provide Nubeqa
Aug 22, 2023 04:05PM Celcuity Enters into a Clinical Trial Collaboration and Supply Agreement with Bayer to Provide Nubeqa® (darolutamide) for Planned Phase 1b/2 Clinical Trial
Aug 22, 2023 04:01PM Celcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial in Metastatic Castration Resistant Prostate Cancer
Aug 10, 2023 04:04PM Celcuity Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
Aug 3, 2023 07:30AM Celcuity Inc. Schedules Release of Second Quarter 2023 Financial Results and Webcast/Conference Call
Jul 31, 2023 08:00AM Celcuity to Participate in the BTIG Virtual Biotechnology Conference 2023
Jun 20, 2023 09:05AM Celcuity (CELC) to Join Russell 2000 and 3000 Indexes
Jun 20, 2023 09:02AM Celcuity Set to Join Russell 2000 and 3000 Indexes
May 24, 2023 08:00AM Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences
May 15, 2023 04:00PM Celcuity Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 12, 2023 06:16AM Celcuity (CELC) Presents Updated Results from Phase 1b Study of Gedatolisib
May 12, 2023 06:15AM Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress
May 8, 2023 05:30PM Celcuity Inc. Schedules Release of First Quarter 2023 Financial Results and Webcast/Conference Call
May 8, 2023 08:00AM Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress
Apr 18, 2023 01:33PM Celcuity (CELC) Presents Preclinical Data on Therapeutic Effects of Gedatolisib
Apr 18, 2023 01:30PM Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023
Apr 12, 2023 08:00AM Celcuity to Participate in 22nd Annual Needham Virtual Healthcare Conference
Mar 23, 2023 04:00PM Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Mar 16, 2023 08:00AM Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Webcast/Conference Call
View More Recent Stories View Older Stories